Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health In Tech (HIT) Research & Development (2024 - 2025)

Historic Research & Development for Health In Tech (HIT) over the last 2 years, with Q3 2025 value amounting to $881562.0.

  • Health In Tech's Research & Development rose 2270.78% to $881562.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year change of. This contributed to the annual value of $2.8 million for FY2024, which is 4035.84% up from last year.
  • Health In Tech's Research & Development amounted to $881562.0 in Q3 2025, which was up 2270.78% from $919000.0 recorded in Q2 2025.
  • Health In Tech's Research & Development's 5-year high stood at $919000.0 during Q2 2025, with a 5-year trough of $633653.0 in Q4 2024.